Literature DB >> 8287507

Systemic diseases associated with intermediate uveitis.

S A Boskovich1, C Y Lowder, D M Meisler, F A Gutman.   

Abstract

BACKGROUND: Intermediate uveitis is characterized by vitreal inflammation with associated inflammation of the vitreous base and peripheral anterior retina and choroid. It may be found as an isolated and idiopathic condition or in association with systemic disorders such as multiple sclerosis and sarcoidosis.
OBJECTIVE: To identify the clinical features of intermediate uveitis and assess its association with systemic diseases.
METHODS: Retrospective study of 83 patients presenting with intermediate uveitis between 1970 and 1991.
RESULTS: Evidence of systemic disorders was found in 26 of 83 patients (31.3%). Of these 26 patients, 10 had presumed sarcoidosis, 6 had multiple sclerosis, 2 had isolated optic neuritis, 2 had inflammatory bowel disease, 4 had isolated thyroid abnormalities, and 2 had histories suggestive of Epstein-Barr virus infection. Associated ocular findings included cystoid macular edema, peripheral retinal perivascular sheathing, cataracts, posterior vitreous detachment, fine keratic precipitates, preretinal macular fibrosis, retinal tears, retinal detachment, and optic disc edema.
CONCLUSIONS: Patients with intermediate uveitis may have associated systemic diseases and should have careful follow-up with regular systemic evaluation.

Entities:  

Mesh:

Year:  1993        PMID: 8287507     DOI: 10.3949/ccjm.60.6.460

Source DB:  PubMed          Journal:  Cleve Clin J Med        ISSN: 0891-1150            Impact factor:   2.321


  13 in total

1.  Soluble ICAM-1 serum levels in patients with intermediate uveitis.

Authors:  A M Klok; L Luyendijk; M J Zaal; A Rothova; A Kijlstra
Journal:  Br J Ophthalmol       Date:  1999-07       Impact factor: 4.638

2.  Is granuloma annulare related to intermediate uveitis with retinal vasculitis?

Authors:  B van Kooij; M Canninga van Dijk; J de Boer; V Sigurdsson; A Rothova
Journal:  Br J Ophthalmol       Date:  2003-06       Impact factor: 4.638

3.  [Intermediate uveitis: guidelines of the German Ophthalmological Society and the Professional Association of German Ophthalmologists].

Authors:  F Mackensen; L Baydoun; J Garweg; A Heiligenhaus; T Hudde
Journal:  Ophthalmologe       Date:  2014-11       Impact factor: 1.059

4.  Hypothyroidism and non-infectious uveitis.

Authors:  Shorya Vardhan Azad; Varun Gogia; Pradeep Venkatesh; Brijesh Takkar
Journal:  Eye (Lond)       Date:  2018-07-24       Impact factor: 3.775

Review 5.  [Guidelines nr. 24a intermediate uveitis].

Authors: 
Journal:  Ophthalmologe       Date:  2021-01       Impact factor: 1.059

6.  Clinical characteristics of intermediate uveitis in Tunisian patients.

Authors:  Moncef Khairallah; Kamel Hmidi; Sonia Attia; Bechir Jelliti; Wafa Hasnaoui; Sonia Zaouali; Salah Jenzeri; Salim Ben Yahia; Riadh Messaoud
Journal:  Int Ophthalmol       Date:  2010-03-05       Impact factor: 2.031

7.  Idiopathic Hypertrophic Cranial Pachymeningitis Associated With Intermediate Uveitis.

Authors:  Sevil Ari Yaylali; Aylin Ardagil Akcakaya; Nihal Işik; Hasan Hasbi Erbil; Ali Olgun; Zeki Aslan; Tulay Kansu
Journal:  Neuroophthalmology       Date:  2011-03-20

8.  [Therapy of intermediate uveitis].

Authors:  D Doycheva; C Deuter; M Zierhut
Journal:  Ophthalmologe       Date:  2014-12       Impact factor: 1.059

9.  Tumor necrosis factor polymorphisms associated with tumor necrosis factor production influence the risk of idiopathic intermediate uveitis.

Authors:  Denize Atan; Jarka Heissigerova; Lucia Kuffová; Aideen Hogan; Dara J Kilmartin; John V Forrester; Jeff L Bidwell; Andrew D Dick; Amanda J Churchill
Journal:  Mol Vis       Date:  2013-01-28       Impact factor: 2.367

Review 10.  Gender and uveitis in patients with multiple sclerosis.

Authors:  Lynn K Gordon; Debra A Goldstein
Journal:  J Ophthalmol       Date:  2014-05-07       Impact factor: 1.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.